I'll give investors little more information, earlier Bio Remedies store site was down no products, Its back up working.
David posted about the Transdermal Pain Patch a few days ago.
Now is there still some type of partnership with Pat Kelly.
As i posted some time ago Bio never the capability to produce the Proprietary Nanotechnology
On March 13, 2025, the University of Maryland BioPark issued an official announcement regarding the merger of Care Beyond Diagnosis LLC and Landrace Bioscience to form 11Three.
11Three uses the same address as Bio Remedies used.
The official media contact for this new multi-million dollar venture is Patrick Kelly at the email address pat@11threetech.com.
11Three’s entire business model is built around "harnessing the power of the revolutionary SENDS® technology."
SENDS: (Solubilized Enhanced Drug Delivery System) is the trade name for that specific "nanotechnology."
As of March 2025: When 11Three was formed via the merger of Landrace Bioscience and Care Beyond Diagnosis, Patrick Kelly was the one who publicly introduced 11Three as the new home for the SENDS platform.
Landrace Bioscience (a massive hemp processor out of Tennessee)
You can verify this by looking at the current 11Three Technology website or their LinkedIn profile, where they describe SENDS as their "revolutionary, pharmaceutical-grade" delivery system.
To give 11Three immediate credibility, they brought in John Dombrowski, MD as the Chief Science Officer.
Dombrowski is a high-profile pain management specialist in D.C.
Having a licensed MD as the face of 11Three allows them to pivot from "Hemp/CBD" (which is struggling legally in MD) to "Pharmaceutical-grade
Bioavailability."
This opens up new revenue streams in oncology, vaccines, and nutraceuticals.
Everyone can form there own opinion..
P L
David posted about the Transdermal Pain Patch a few days ago.
Now is there still some type of partnership with Pat Kelly.
As i posted some time ago Bio never the capability to produce the Proprietary Nanotechnology
On March 13, 2025, the University of Maryland BioPark issued an official announcement regarding the merger of Care Beyond Diagnosis LLC and Landrace Bioscience to form 11Three.
11Three uses the same address as Bio Remedies used.
The official media contact for this new multi-million dollar venture is Patrick Kelly at the email address pat@11threetech.com.
11Three’s entire business model is built around "harnessing the power of the revolutionary SENDS® technology."
SENDS: (Solubilized Enhanced Drug Delivery System) is the trade name for that specific "nanotechnology."
As of March 2025: When 11Three was formed via the merger of Landrace Bioscience and Care Beyond Diagnosis, Patrick Kelly was the one who publicly introduced 11Three as the new home for the SENDS platform.
Landrace Bioscience (a massive hemp processor out of Tennessee)
You can verify this by looking at the current 11Three Technology website or their LinkedIn profile, where they describe SENDS as their "revolutionary, pharmaceutical-grade" delivery system.
To give 11Three immediate credibility, they brought in John Dombrowski, MD as the Chief Science Officer.
Dombrowski is a high-profile pain management specialist in D.C.
Having a licensed MD as the face of 11Three allows them to pivot from "Hemp/CBD" (which is struggling legally in MD) to "Pharmaceutical-grade
Bioavailability."
This opens up new revenue streams in oncology, vaccines, and nutraceuticals.
Everyone can form there own opinion..
P L
7
